GSK, UNC Chapel partner to accelerate search for HIV cure
Under the public-private partnership (PPP), research scientists from both parties will work together in an HIV Cure center, which will be located at UNC. The two entities will
The US Food and Drug Administration (FDA) has expanded the approved indication for Bristol Myers Squibb’s (BMS) Camzyos (mavacamten) to treat symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in adults and paediatric patients weighing at least 30kg (66lb).
Under the deal, Cyclenium’s CMRT Technology-derived QUEST Library and associated hit-to-lead optimization expertise will be combined with Haplogen’s haploid genetics technology and expertise in host target identification, validation